Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2

Multigene panel testing results in patients with multiple breast cancer primaries

(2020) Jessica Corredor et al.   Breast Journal

Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test

(2020) Hee-Chul Shin et al.   Cancer Research and Treatment

Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)—Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes

(2020) Lorena Incorvaia et al.   Cancers

The prognostic comparison among unilateral, bilateral, synchronous bilateral, and metachronous bilateral breast cancer: A meta‐analysis of studies from recent decade (2008‐2018)

(2019) Bo Pan et al.   Cancer Medicine

Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

(2019) N Stjepanovic et al.   ANNALS OF ONCOLOGY

Bilateral breast cancers in an Asian population, and a comparison between synchronous and metachronous tumours

(2018) Yirong Sim et al.   ANZ JOURNAL OF SURGERY

Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations

(2018) Christian F. Singer et al.   EUROPEAN JOURNAL OF CANCER

Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology

(2018) Therese B. Bevers et al.   Journal of the National Comprehensive Cancer Network

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

(2017) Karoline B. Kuchenbaecker et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer

(2017) Gianluca Tedaldi et al.   Oncotarget

The Role of Genetic Testing in Patients With Breast Cancer

(2017) Olivia M. Valencia et al.   JAMA Surgery

HGVS Recommendations for the Description of Sequence Variants: 2016 Update

(2016) Johan T. den Dunnen et al.   HUMAN MUTATION

Bilateral Oophorectomy and Breast Cancer Risk inBRCA1andBRCA2Mutation Carriers

(2016) Joanne Kotsopoulos et al.   JNCI-Journal of the National Cancer Institute

Bilateral Oophorectomy and Breast Cancer Risk inBRCA1andBRCA2Mutation Carriers

(2016) Joanne Kotsopoulos et al.   JNCI-Journal of the National Cancer Institute

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2015) E. Senkus et al.   ANNALS OF ONCOLOGY

Beyond BRCA: New hereditary breast cancer susceptibility genes

(2015) P. Economopoulou et al.   CANCER TREATMENT REVIEWS

Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

(2015) Douglas F. Easton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment

(2015) Andrea Desmond et al.   JAMA Oncology

Frequency of mutations in individuals with breast cancer referred forBRCA1andBRCA2testing using next-generation sequencing with a 25-gene panel

(2014) Nadine Tung et al.   CANCER

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients

(2014) Holly LaDuca et al.   GENETICS IN MEDICINE

Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment

(2014) Allison W. Kurian et al.   JOURNAL OF CLINICAL ONCOLOGY

Bilateral breast cancers

(2014) Steven A. Narod   Nature Reviews Clinical Oncology

DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples

(2013) Michele Simbolo et al.   PLoS One

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

(2013) J. Gao et al.   Science Signaling

Hereditary Breast Cancer: The Era of New Susceptibility Genes

(2013) Paraskevi Apostolou et al.   Biomed Research International

CHEK2*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death, Breast Cancer–Specific Death, and Increased Risk of a Second Breast Cancer

(2012) Maren Weischer et al.   JOURNAL OF CLINICAL ONCOLOGY

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

(2011) K Metcalfe et al.   BRITISH JOURNAL OF CANCER

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

(2010) Ramūnas Janavičius   EPMA Journal

The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer

(2009) Wenli Lu et al.   EUROPEAN JOURNAL OF CANCER

Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

(2009) Monika K. Graeser et al.   JOURNAL OF CLINICAL ONCOLOGY

Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?

(2008) Antonio Russo et al.   BREAST CANCER RESEARCH AND TREATMENT

Frequency of the CHEK2 1100delC Mutation among Women with Breast Cancer: An International Study

(2008) S. Zhang et al.   CANCER RESEARCH

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results

(2008) Sharon E. Plon et al.   HUMAN MUTATION